Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Are cases of mumps in vaccinated patients attributable to mismatches in both vaccine T-cell and B-cell epitopes?: An immunoinformatic analysis.

Homan EJ, Bremel RD.

Hum Vaccin Immunother. 2014;10(2):290-300. doi: 10.4161/hv.27139. Epub 2013 Nov 25.

2.

Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak.

Rubin SA, Qi L, Audet SA, Sullivan B, Carbone KM, Bellini WJ, Rota PA, Sirota L, Beeler J.

J Infect Dis. 2008 Aug 15;198(4):508-15. doi: 10.1086/590115.

PMID:
18558869
3.

Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks?

Dayan GH, Rubin S.

Clin Infect Dis. 2008 Dec 1;47(11):1458-67. doi: 10.1086/591196.

PMID:
18959494
4.

Variability of hemagglutinin-neuraminidase and nucleocapsid protein of vaccine and wild-type mumps virus strains.

Ivancic-Jelecki J, Santak M, Forcic D.

Infect Genet Evol. 2008 Sep;8(5):603-13. doi: 10.1016/j.meegid.2008.04.007. Epub 2008 Apr 22.

PMID:
18508415
5.
6.

Cross-neutralization between three mumps viruses & mapping of haemagglutinin-neuraminidase (HN) epitopes.

Vaidya SR, Dvivedi GM, Jadhav SM.

Indian J Med Res. 2016 Jan;143(1):37-42. doi: 10.4103/0971-5916.178587.

7.

Comparative efficacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population.

Ong G, Goh KT, Ma S, Chew SK.

J Infect. 2005 Nov;51(4):294-8. Epub 2004 Nov 5.

PMID:
16291282
8.

Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein.

Cusi MG, Fischer S, Sedlmeier R, Valassina M, Valensin PE, Donati M, Neubert WJ.

Virus Res. 2001 Apr;74(1-2):133-7.

PMID:
11226581
9.

[Mumps epidemic in vaccinated children in West Switzerland].

Ströhle A, Eggenberger K, Steiner CA, Matter L, Germann D.

Schweiz Med Wochenschr. 1997 Jun 28;127(26):1124-33. German.

PMID:
9312835
10.

Effectiveness of a vaccination program against mumps in Ukraine.

Hrynash Y, Nadraga A, Dasho M.

Eur J Clin Microbiol Infect Dis. 2008 Dec;27(12):1171-6. doi: 10.1007/s10096-008-0575-6. Epub 2008 Jul 11.

PMID:
18618156
11.

In vitro and in vivo growth alter the population dynamic and properties of a Jeryl Lynn mumps vaccine.

Connaughton SM, Wheeler JX, Vitková E, Minor P, Schepelmann S.

Vaccine. 2015 Aug 26;33(36):4586-93. doi: 10.1016/j.vaccine.2015.06.109. Epub 2015 Jul 15.

12.

Mumps virus strains isolated in Croatia in 1998 and 2005: Genotyping and putative antigenic relatedness to vaccine strains.

Santak M, Kosutić-Gulija T, Tesović G, Ljubin-Sternak S, Gjenero-Margan I, Betica-Radić L, Forcić D.

J Med Virol. 2006 May;78(5):638-43.

PMID:
16555272
13.

Dynamics of the serologic response in vaccinated and unvaccinated mumps cases during an epidemic.

Kaaijk P, Gouma S, Hulscher HI, Han WG, Kleijne DE, van Binnendijk RS, van Els CA.

Hum Vaccin Immunother. 2015;11(7):1754-61. doi: 10.1080/21645515.2015.1040967.

14.

Novel polyvalent live vaccine against varicella-zoster and mumps virus infections.

Matsuura M, Somboonthum P, Murakami K, Ota M, Shoji M, Kawabata K, Mizuguchi H, Gomi Y, Yamanishi K, Mori Y.

Microbiol Immunol. 2013 Oct;57(10):704-14. doi: 10.1111/1348-0421.12087.

15.

Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies.

Šantak M, Lang-Balija M, Ivancic-Jelecki J, Košutić-Gulija T, Ljubin-Sternak S, Forcic D.

Epidemiol Infect. 2013 Jun;141(6):1298-309. doi: 10.1017/S0950268812001896. Epub 2012 Sep 7.

PMID:
22954346
16.

Phylogenetic analysis of clinical mumps virus isolates from vaccinated and non-vaccinated patients with mumps during an outbreak, Switzerland 1998-2000.

Utz S, Richard JL, Capaul S, Matter HC, Hrisoho MG, Mühlemann K.

J Med Virol. 2004 May;73(1):91-6.

PMID:
15042654
17.

[Comparison of the efficacy of various strains of mumps vaccine: a school survey].

Toscani L, Batou M, Bouvier P, Schlaepfer A.

Soz Praventivmed. 1996;41(6):341-7. French.

PMID:
9027138
18.

[Community effectiveness of vaccines against infectious parotiditis (mumps). Report of cases].

Limón Mora J, Molina López T, Domínguez Camacho JC.

Rev Esp Salud Publica. 1999 Jul-Aug;73(4):455-64. Spanish.

19.

Infants' responses to live, attenuated, B level, Jeryl Lynn mumps vaccine.

Wilkins J, Williams FF, Wehrle PF.

Am J Dis Child. 1972 Jul;124(1):66-7. No abstract available.

PMID:
5033752
20.

[Comment on: Ströhle A, Eggenberger K, Steiner CA, Matter L, Germann D: Studies of the mumps epidemic in vaccinated children in Western Switzerland].

Gasser-Bachmann M.

Schweiz Med Wochenschr. 1997 Nov 22;127(47):1970-1. German. No abstract available.

PMID:
9480538

Supplemental Content

Support Center